the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email .

Share this:
Brief Title Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Official Title Topoisomerase 2-Alpha (TOPO2A) Genomic Alterations and Immunohistochemical Expression as Well as Chromosome 17 Polysomy in Advanced or Recurrent Endometrial Carcinoma Treated With Anthracycline-Based Therapy
Principal Investigator Fleming, Gini
Brief Summary This research study is studying biomarkers in tissue samples from patients with stage III, stage IV, or recurrent endometrial cancer. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer.
Gender Female
Ages 18 Years
Enrollment 169
Accepts Healthy Volunteers No
Lead Sponsor Gynecologic Oncology GroupOther
Collaborator National Cancer Institute (NCI)NIH
Study Design Observational Model: Cohort, Time Perspective: Retrospective
Study Phase N/A
Study Type Observational
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Recurrent Uterine Corpus Carcinoma
Detail for Health Professional (on
More clinical trials by this PI